Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on September 4, 2017 has expired with 154,100 shares, representing 1.72% for ¥421.62 million.
September 04, 2017
Share
The company expired its plan on September 5, 2017.
Fuso Pharmaceutical Industries, Ltd. is a Japan-based company principally involved in the manufacture and sale of pharmaceuticals and medical equipment for medical purposes. The Company operates in two business segments. The Pharmaceuticals segment is involved in manufacture and sale of pharmaceutical products, including injectable drugs, which mainly focus on infusion solution, dialysis fluid for artificial kidney, as well as the manufacture and sale of medical equipment and instruments. The Real Estate segment is engaged in the leasing of real estate properties.
Fuso Pharmaceutical Industries,Ltd.'s Equity Buyback announced on September 4, 2017 has expired with 154,100 shares, representing 1.72% for ¥421.62 million.